{"organizations": ["American College of Gastroenterology Annual", "Neurocrine Biosciences, Inc.", "Neurocrine Biosciences", "Cancer Institute"], "uuid": "4016b666e8dbef1a1fb4fc89a7dd7e3983ee4907", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Global-Therapeutic-Drug-Monitoring-Technologies--Markets--and-Companies-Report-2015---Updated-2015-Analysis-with-Forecasts-to-2024-47942-1/", "country": "US", "title": "Global Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2015 - Updated 2015 Analysis with Forecasts to 2024", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Global Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2015 - Updated 2015 Analysis with Forecasts to 2024", "spam_score": 0.0, "site_type": "news", "published": "2015-09-02T20:09:00.000+03:00", "replies_count": 0, "uuid": "4016b666e8dbef1a1fb4fc89a7dd7e3983ee4907"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Global-Therapeutic-Drug-Monitoring-Technologies--Markets--and-Companies-Report-2015---Updated-2015-Analysis-with-Forecasts-to-2024-47942-1/", "ord_in_thread": 0, "title": "Global Therapeutic Drug Monitoring Technologies, Markets, and Companies Report 2015 - Updated 2015 Analysis with Forecasts to 2024", "locations": ["UK", "London", "DUBLIN"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": ["Jain PharmaBiotech", "Takeda"], "text": "  2015 Research and Markets ( http://www.researchandmarkets.com/research/cnq7tc/medical_device ... \"Medical Device Studies: Clinical Evidence (London, UK - ... This course has been designed ... clinical evidence required for medical devices and in-vitro ... medical devices and the emphasis on high quality,   2015 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... Officer of Neurocrine Biosciences, will be presenting at the ... City . The live presentation takes ... PT). The presentation will be webcast and may be ... Listeners are encouraged to visit the   DUBLIN , Sept. 2, 2015 ... the addition of Jain PharmaBiotech,s new report ... Technologies, Markets and Companies\" to their offering. ... cell biology of the BBB have opened new ... the CNS. Several carrier or transport systems, enzymes, ... [ 0 ] Medical Device Studies: Clinical Evidence Course - London, UK - November 10-11, 2015 [ 0 ] Neurocrine Biosciences to Present at the Baird 2015   Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 ... October 7 , - 125 Patient, Prospective ... Overall Survival, Bavarian Nordic has now evaluated ... cancer vaccine candidate PROSTVAC(TM) that had been,obtained as ... National,Cancer Institute (NCI) in the US., The ... ... Data Presented at the American College of Gastroenterology Annual ... ... Oct. 6 Combined results from two Phase 3,studies presented at ... demonstrated that TAK-390MR,resulted in higher healing rates than lansoprazole among patients ... Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed  ", "external_links": [], "published": "2015-09-02T20:09:00.000+03:00", "crawled": "2015-09-03T03:06:58.371+03:00", "highlightTitle": ""}